Cost Effectiveness of Glargine Insulin Versus NPH Insulin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01832935
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose basic science
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT01832935
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT01832935. Randomized; double masking; primary purpose basic science. Start 2011-07 (registry gives no type); primary completion 2012-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cost Effectiveness of Glargine Insulin Versus NPH Insulin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- insulin glargine
- Intervention (Drug)
- Insulin NPH
- Lead sponsor
- Tehran University of Medical Sciences
Record details
- Record id
cardio:ct-nct01832935- Content hash
4fc413f8a8a1fba6c243a60a7eac922cffbe91f0e9cd2c50d04a3f5232e5bb94